STOCKHOLM, April 23, 2021 /PRNewswire/ — The Patent and Market Court of Appeal at the Svea Court of Appeal partly confirms the judgment of the Patent and Market Court of 26 July 2019, which gave C-RAD the right to the invention described in the patent application entitled “Ionizing radiation detecting device”.
The disputed invention is closely related to the research and development of C-RAD’s image detector called ‘Gemini’.
Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient’s motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy.